Raymond James Financial Inc Axogen, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 276,200 shares of AXGN stock, worth $5.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
276,200Holding current value
$5.2 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXGN
# of Institutions
170Shares Held
36.5MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$77.1 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$61.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$56.6 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$54.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$45.7 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $797M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...